| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.091 | 2.452 | 557 | 0 | 799 | 608 | 8.923 | 16.591 | 35.810 | 0 |
| Total Income - EUR | 4.664 | 3.545 | 560 | 0 | 799 | 608 | 8.923 | 16.591 | 35.810 | 0 |
| Total Expenses - EUR | 10.338 | 4.529 | 4.161 | 4.162 | 1.515 | 584 | 10.094 | 6.539 | 5.141 | 3.443 |
| Gross Profit/Loss - EUR | -5.674 | -984 | -3.600 | -4.162 | -716 | 24 | -1.171 | 10.053 | 30.669 | -3.443 |
| Net Profit/Loss - EUR | -5.674 | -984 | -3.600 | -4.162 | -716 | 6 | -1.315 | 9.555 | 25.762 | -3.443 |
| Employees | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Bioterpena Sistem S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.366 | 5.845 | 3.748 | 1.530 | 2.154 | 2.147 | 2.492 | 10.235 | 2.358 | 807 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.265 | 4.928 | 3.016 | 1.252 | 2.154 | 2.057 | 558 | 661 | 661 | 798 |
| Cash | 1.101 | 917 | 732 | 278 | 0 | 90 | 1.934 | 9.574 | 1.697 | 9 |
| Shareholders Funds | -92.169 | -92.213 | -94.253 | -96.686 | -95.529 | -93.713 | -92.949 | -83.683 | -57.667 | -60.789 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 98.535 | 98.058 | 98.001 | 98.216 | 97.684 | 95.860 | 95.441 | 93.918 | 60.025 | 61.595 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Bioterpena Sistem S.r.l.